menu

CINtec PLUS Cytology: A New Biomarker-Based Triage in Cervical Cancer Screening

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
Roche

CINtec PLUS Cytology: A New Biomarker-Based Triage in Cervical Cancer Screening

CINtec PLUS Cytology: A New Biomarker-Based Triage in Cervical Cancer Screening
RestartResume

Does this biomarker-based cytology test have the potential to change the way we think about cervical cancer screening?

  • Sponsored by

  • Overview

    The Pap test has played a key role in reducing cervical cancer since its introduction in the 1940s, but like any test, it isn’t without its limitations. Joining Dr. Jennifer Caudle to discuss how CINtec PLUS Cytology, a biomarker-based cytology test, aims to overcome those challenges is Dr. Ritu Nayar.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 10/22/20